Lv2
140 积分 2021-12-12 加入
Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer
2天前
已完结
Phase separation of phospho-HDAC6 drives aberrant chromatin architecture in triple-negative breast cancer
3个月前
已完结
Unravelling the obesity paradox in MASLD patients with extrahepatic cancer
3个月前
已关闭
Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
3个月前
已完结
KDM3A Ablation Activates Endogenous Retrovirus Expression to Stimulate Antitumor Immunity in Gastric Cancer
4个月前
已完结
CXCL9 and CXCL10 bring the heat to tumors
5个月前
已完结
ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity
5个月前
已完结
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
5个月前
已完结
Targeting the tumour stroma to improve cancer therapy
5个月前
已完结
Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial
5个月前
已完结
皖公网安备34019202002308
